We are Shaping the Future! Showcasing Success Stories as We Innovate for a Sustainable Tomorrow

SF2030 Topics "Extension of Healthy Life Expectancy"

Integrated Report 2024: Long Term Vision SF2030 Topics

Helping People Fulfill Their Desire to Stay Healthy through Preventive Care

For "extension of healthy life expectancy," as one of the targets of SF2030, OMRON aims to contribute to a society where people can pursue individual fulfillment by staying healthy.

 

Health management at home as preventive care for serious diseases

OMRON Healthcare, in charge of the healthcare business, is implementing initiatives to extend healthy life expectancy centering on cardiovascular diseases, respiratory diseases, and pain management under the vision "Going for ZERO, Preventive Care for the Health of Society."

For cardiovascular diseases, OMRON has been partnering with healthcare professionals to promote home blood pressure monitoring for more than 40 years. Today, home blood pressure monitoring has become standard practice for hypertension management, and its market is expanding globally. We will continue to focus on further market penetration of home blood pressure monitoring in cooperation with academic societies in various countries. This year we again extended cooperation for the May Measurement Month; a global blood pressure screening awareness campaign held every May in more than 100 countries around the world on the initiative of the International Society of Hypertension (ISH). To date, OMRON has donated a cumulative total of more than 20,000 blood pressure monitors and more than 4 million people have had their blood pressure measured in this campaign. In addition, we are working to encourage ECG recording at home for early detection of AFib, which is one of the causes of stroke. In February 2024, we launched a new portable ECG device that can easily record ECG when subjective symptoms such as chest pain or palpitations are felt at home or when out and about. By making ECG checks, which are normally performed at healthcare institutions and during medical checkups, more accessible, we will help reduce cerebrovascular and cardiovascular events.

In fiscal 2023, demand for nebulizers for healthcare institutions increased due to a sharp rise in the number of patients with respiratory diseases in China, and the sales marked a record high in the online market. A nebulizer is a medical device used to deliver medications for asthma, etc. to the bronchi and lungs in the form of a fine mist. The number of patients suffering from asthma and other respiratory diseases continues to increase, especially in China and other developing countries where air pollution persists. We are contributing to the treatment of asthma and prevention of aggravation through the global provision of nebulizers, which are useful in the treatment of respiratory diseases.

Regarding pain management to alleviate chronic pain, we are working to create a new market in the sports recovery domain for alleviating muscle fatigue and muscle pain after exercise by applying TENS. Through partnerships with professional soccer and basketball teams, as well as universities and high schools with notable clubs, we aim to expand product recognition in the sports recovery market. From the treatment of chronic pain to conditioning for athletes, we aim to help more people lead their daily lives without worrying about pain.

1476_02.jpgTENS / ECG device / Nebulizer

 

Remote patient monitoring service to support medical treatment

In April 2024, OMRON Healthcare acquired all issued shares of Luscii, provider of a remote patient monitoring service in Europe. We entered a business partnership with Luscii in 2018, linking our devices with Luscii's treatment support programs. By making Luscii a wholly owned subsidiary, we strengthen and accelerate the remote patient monitoring service business in Europe.

Healthcare support solutions provided by Luscii include care plans based on biometric data measured at home and care at home programs to help maintain treatment. This service has been introduced in about 70 major hospitals, mainly in the Netherlands and the U.K., and is used to improve the efficiency of medical care and prevent aggravation.

The greatest strength is that the programs offered by Luscii cover more than 150 diseases including not only cardiovascular and respiratory diseases but also COVID-19, cancer, inflammatory bowel disease, and diabetes. By integrating the strengths of our devices and know-how with Luscii's healthcare support solutions, we will develop remote patient monitoring services to provide appropriate treatment to more patients.

 

Creating new value through preventive care and extending healthy life expectancy

OMRON Healthcare will continue striving to extend the healthy life expectancy of people around the world by providing devices and services that facilitate early detection of disease and early intervention for treatment, to "prevent illness," "prevent aggravation," and "prevent recurrence of serious illness."

 

intrport.jpg